Get started
SHENZHEN CHIPSCREEN BIOSCIENCES COSHENZHEN CHIPSCREEN BIOSCIENCES COSHENZHEN CHIPSCREEN BIOSCIENCES CO

SHENZHEN CHIPSCREEN BIOSCIENCES CO

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

688321 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of small molecule drugs. Its products include original medicine such as Chidamide, Chiglitazar, Chiauranib. It also engages in technological licensing. The company was founded by Xian Ping Lu and Zhi Qiang Ning on March 21, 2001 and is headquartered in Shenzhen, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
688321 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company